Pathogenic Mechanisms - Mechanism of Injury
In most glomerular diseases, in which the kidney is the primary focus of the disease process,injury is believed to occur through immunological processes. The primary indicator of this association comes from the regular finding by immuno-fluorescent staining of immune reactants (IgG, IgM, IgA, C3, or C4) within the glomeruli .
Complement can be activated through the binding of antigen by specific antibody (IgG or IgM). Three modes of antigen-antibody interaction have been described for the activation of complement within the glomerulus. Circulating immune complexes (CIC) form within the circulation and may be trapped in the glomerular capillary wall during ultrafiltration. In situ immune complex formation takes place when circulating free antigen lodges within the glomerulus and antibody subsequently binds to the trapped antigen. Finally, antirenal antibody (specifically, anti-glomerular basement membrane antibody) may form, bind to an element of the glomerulus, and activate injury pathways.
Complement activation via the classic pathway is inferred from the presence of IgG or IgM plus C4 and C3 within glomeruli. The presence of C3, sometimes with properdin, but the absence of C4 and IgG or IgM indicates alternate pathway complement activation within glomeruli.
Attraction of polymorphonuclear leukocytes (PMN’s) appears to be the most direct consequence of immune complex complement activation. However, injury does occur in a number of glomerular diseases associated with immune deposits in which PMN infiltration is minimal or absent. Moreover, in some common human glomerulopathies, immune reactants are absent. The mode of glomerular injury and/or dysfunction in these instances is uncertain. Glomerular injury in diseases such as diabetes mellitus and amyloidosis likely proceeds from a metabolic etiology. Finally, hemodynamic insults to the glomerular capillary bed may lead to glomerular necrosis, as in the case of severe hypertension, or sclerosis, as with sustained glomerular hyperfiltration.
- NONATHEROSCLEROTIC CAUSES OF CORONARY ARTERY OBSTRUCTION
- Clinical Manifestations
- ANGINA PECTORIS
- Studies of Pancreatic Structure and Function
- PATHOLOGY
- ELECTRICAL CONDUCTION SYSTEM
- EFFECTS OF PULMONARY HYPERTENSION ON PULMONARY FUNCTION
- Clinical Manifestations
- APPROACH TO THE PATIENT WITH SUSPECTED OR CONFIRMED ARRHYTHMIAS
- Laparoscopy
- MEDIASTINITIS
- Complications of Dialysis
- Women’s Health Program
- Pathogenic Mechanisms
- Pulmonary Vasculitis
- Management
- CLASSIFICATION AND PATHOPHYSIOLOGY
- PROGNOSIS
- Phenytoin
- SPECIFIC ENTITIES - DISEASES WITH KFiOWIi ETIOLOGIES -
- COMMON PRESENTING COMPLAINTS
- ACUTE PANCREATITIS
- CLINICAL FEATURES OF PULMONARY HYPERTENSION
- Minimal Change Nephropathy
- ARTERJAL BLOOD GASES
- Beta Blockers
- DEFINITION
- Disorders of Pregnancy
- Chronic Interstitial Nephritis
- PULMONARY GAS EXCHANGE
- Renal Artery Stenosis
- RENAL PHARMACOLOGY
- POLYPS OF THE GASTROINTESTINAL TRACT
- NONMEDICAL MANAGEMENT OF ANGINA PECTORIS
- CHRONIC RENAL FAILURE